Sasha Damouni Ellis | VP, Corporate Communications, and IR |
Scott Braunstein | Chief Executive Officer |
Joe Hulihan | Chief Medical Officer |
Steve Pfanstiel | Chief Financial Officer |
Mark Paternoster | Medicines Development Leader |
Christy Shafer | Chief Commercial Officer |
Marc Goodman | SVB |
Joseph Thome | Cowen |
Andrew Tsai | Jefferies |
Douglas Tsao | H.C. Wainwright |
Brian Skorney | Baird |
Joon Lee | Truist Securities |
Jay Olson | Oppenheimer |
Greetings, and welcome to the Marinus Pharmaceuticals First Quarter 2022 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] And now it is my pleasure to introduce your host, Sasha Damouni Ellis, Vice President of Corporate Affairs and Investor Relations.
You may begin.